SHL Telemedicine SHMLF 6-K notes launch of shareholder rights offer

Rhea-AI Filing Summary

SHL Telemedicine Ltd. filed a Form 6-K reporting that it has issued a press release titled “SHL Telemedicine launches rights offering.” The company is a foreign private issuer based in Tel Aviv, Israel, and the press release is attached as an exhibit and incorporated by reference into this report. The filing itself mainly serves to formally notify investors that details of the planned rights offering are provided in the accompanying press release.

Insights

Equity Capital Markets Analyst

SHL Telemedicine announces a planned rights offering via attached press release.

SHL Telemedicine Ltd. uses this Form 6-K to inform investors that it has released a press statement titled “SHL Telemedicine launches rights offering.” A rights offering typically allows existing shareholders to buy additional shares, usually at a set subscription price and within a defined period, in order to raise equity capital.

The filing does not disclose specific terms such as subscription price, number of rights, or targeted proceeds, directing readers instead to the attached press release. Without those figures, the scale of potential dilution or capital raised cannot be assessed from this report alone.

Subsequent company communications and future filings that describe the rights offering’s terms, timing, and take-up levels will provide the information needed to understand its full impact on ownership and capital structure.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-41641

SHL TELEMEDICINE LTD.

(Translation of registrant’s name into English)

 90 Yigal Alon Street

Tel Aviv 67891, Israel

(Address of principal executive offices)

_____________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒           Form 40-F ☐

EXPLANATORY NOTE

On November 21, 2025, SHL Telemedicine Ltd. issued a press release titled “SHL Telemedicine launches rights offering”, a copy of which is furnished herewith as Exhibit 99.1, and which is incorporated by reference herein.

EXHIBIT INDEX

Exhibit Description

99.1 Press release, dated November 21, 2025, titled “SHL Telemedicine launches rights offering”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SHL TELEMEDICINE LTD.
	By:	/s/ Lior Haalman
		Lior Haalman
		Chief Financial Officer

November 21, 2025

3

FAQ

What did SHMLF disclose in this Form 6-K filing?

SHL Telemedicine Ltd. reported that it issued a press release titled “SHL Telemedicine launches rights offering”, which is attached as an exhibit and incorporated by reference.

What is the main purpose of SHL Telemedicines November 2025 Form 6-K?

The main purpose is to formally furnish a press release announcing that SHL Telemedicine has launched a rights offering, making that information part of its official U.S. disclosure record.

Does the SHMLF Form 6-K describe the terms of the rights offering?

No specific terms such as price, number of shares, or timetable are described in this report. It only states that a press release about the rights offering is attached as Exhibit 99.1.

Where can investors find more details on SHL Telemedicines rights offering?

Investors are directed to the press release titled “SHL Telemedicine launches rights offering,” furnished as Exhibit 99.1 to this Form 6-K for detailed information.

What type of issuer is SHL Telemedicine under U.S. securities rules?

SHL Telemedicine Ltd. is identified as a foreign private issuer and submits this report under Form 6-K requirements.